Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag
M Jiang, P Chen, X Guo, X Zhang, Q Gao, J Zhang… - EJNMMI research, 2023 - Springer
Background The high incidence of epidermal growth factor receptor (EGFR) mutations is
usually found in female patients with lung adenocarcinoma who have never-smoked …
usually found in female patients with lung adenocarcinoma who have never-smoked …
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer
Background EGFR mutation-induced cell proliferation causes changes in tumor biology and
tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on …
tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on …
Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma
B Mohar, S Smojver Ježek, K Rajković Molek… - …, 2016 - Wiley Online Library
Objective Epidermal growth factor receptors (EGFR) mutation status is crucial for the
prediction of a tumour response to treatment with EGFR tyrosine kinase (EGFR‐TK) …
prediction of a tumour response to treatment with EGFR tyrosine kinase (EGFR‐TK) …
Clinicopathological features associated with EGFR gene mutation in non-small cell lung cancer patients
J Zhou, W Mo, J Zhao, J Zheng, W Ding - Zhonghua yi xue za zhi, 2014 - europepmc.org
Objective To explore the clinicopathological features associated with epidermal growth
factor receptor (EGFR) gene mutation in non-small cell lung cancer (NSCLC) patients …
factor receptor (EGFR) gene mutation in non-small cell lung cancer (NSCLC) patients …
EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment
D Que, H Xiao, B Zhao, X Zhang, Q Wang… - Cancer biology & …, 2016 - Taylor & Francis
Objective: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) can
effectively control non-small cell lung cancer (NSCLC). Therefore, EGFR mutations should …
effectively control non-small cell lung cancer (NSCLC). Therefore, EGFR mutations should …
EGFR mutations in non-small cell lung cancer: an audit from West China Hospital
Y Tang, W Wang, K Zheng, L Jiang, Y Zou… - Expert Review of …, 2016 - Taylor & Francis
Objectives: To discover the incidence and characteristics of EGFR mutations in non-small
cell lung cancer (NSCLC) in a single, large cohort as a part of routine diagnostic …
cell lung cancer (NSCLC) in a single, large cohort as a part of routine diagnostic …
Inter-and intratumor heterogeneity of EGFR compound mutations in non–small cell lung cancers: analysis of five cases
K Suda, K Sakai, K Obata, S Ohara, T Fujino, T Koga… - Clinical Lung Cancer, 2021 - Elsevier
Background Several clinical and preclinical studies suggest that non–small cell lung
cancers (NSCLCs) with EGFR compound mutations were associated with lower efficacies of …
cancers (NSCLCs) with EGFR compound mutations were associated with lower efficacies of …
The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study
P Krawczyk, R Ramlau… - Journal of cancer …, 2015 - Springer
Introduction Testing for the epidermal growth factor receptor (EGFR) gene mutations
requires considerable multidisciplinary experience of clinicians (for appropriate patient …
requires considerable multidisciplinary experience of clinicians (for appropriate patient …
[HTML][HTML] EGFR mutation detection and its association with clinicopathological characters of lung cancer patients
Background Lung cancer is the most common type of cancer worldwide with an estimation of
1.82 million new cancer cases diagnosed; and it is the leading cause of cancer-related …
1.82 million new cancer cases diagnosed; and it is the leading cause of cancer-related …
Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung …
L Zhu, G Yin, W Chen, X Li, X Yu, X Zhu… - Thoracic …, 2019 - Wiley Online Library
Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …
相关搜索
- male patients lung cancer
- cell lung cancer patients
- small cell lung cancer
- egfr mutation lung adenocarcinoma
- scc ag cyfra21 1
- tomography image lung adenocarcinoma
- cytological specimens lung adenocarcinoma
- tumor tissues egfr tki
- f18 fluorodeoxyglucose lung adenocarcinoma
- tumor tissues predictor of response
- male patients scc ag
- scc ag lung cancer
- male patients cyfra21 1
- lung cancer cyfra21 1
- egfr mutation cytological specimens
- f18 fluorodeoxyglucose tomography image